Psychemedics Releases 2026 Workforce Insights Report
Psychemedics Releases 2025 Workforce Insights Report
Psychemedics Named “Most Innovative Drug Testing Company of the Year”
Psychemedics Corporation Announces Reverse and Forward Stock Split
Psychemedics Corporation Reports Third Quarter 2024 Financial Results
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
Psychemedics Corporation Reports Second Quarter 2024 Financial Results
Psychemedics Corporation's Board of Directors Approves Plan to Terminate Registration of Its Common Stock
Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing
Psychemedics Corporation Reports First Quarter 2024 Financial Results
Psychemedics Corporation Reports 2023 Financial Results
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
Psychemedics Corporation Reports Third Quarter 2023 Financial Results
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Psychemedics Corporation Reports Second Quarter 2023 Financial Results
Psychemedics Corporation Announces CEO Succession Plan
Psychemedics: 21% Sales Growth But Net Loss, Takeover Possibility, Covid Recovery Play
Small And Microcap Newsletter: DHT Holdings Financials Give It Time Until The Next Tanker Bull Market
Psychemedics: Q3 Revenues +29%, Margins Surge, Possible Corporate Actions Including Dividend
Psychemedics: Market Leader, 8% FCF Yield, Possible Takeover Target
Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results
Montana Advisors Writes Open Letter to Psychemedics
Psychemedics Corporation Reports First Quarter 2021 Financial Results
Psychemedics Corporation Reports Fourth Quarter and Full Year 2020 Financial Results
Robyn C. Davis Joins Psychemedics Board of Directors
Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller
Psychemedics Announces Third Quarter Results